Evidence map›Paper›PMID 31610848›Full record

ArticleeLife2019

Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin.

Cassandra L Stowe, Thomas A Burley, Helen Allan, Maria Vinci, Gabriela Kramer-Marek, Daniela M Ciobota, Gary N Parkinson, Tara L Southworth, Giulia Agliardi, Alastair Hotblack and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. OptimizediScience · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Red-Shifted Coumarin Luciferins for Improved Bioluminescence Imaging.Journal of the American Chemical Society · 2023
    Article
  11. Article
  12. Article
  13. The Role of Optical Imaging in Translational Nanomedicine.Journal of functional biomaterials · 2022
    Review
  14. Article
  15. A higher spectral range of beetle bioluminescence with infraluciferin.Frontiers in bioengineering and biotechnology · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Cassandra L StoweCancer Institute, University College London, London, United Kingdom.
Thomas A BurleyThe Institute of Cancer Research, London, United Kingdom.
Helen AllanDepartment of Chemistry, University College London, London, United Kingdom.
Maria VinciThe Institute of Cancer Research, London, United Kingdom.
Gabriela Kramer-MarekThe Institute of Cancer Research, London, United Kingdom.
Daniela M CiobotaThe Institute of Cancer Research, London, United Kingdom.
Gary N ParkinsonSchool of Pharmacy, University College London, London, United Kingdom.
Tara L SouthworthDepartment of Chemistry, Connecticut College, New London, United States.
Giulia AgliardiCancer Institute, University College London, London, United Kingdom.
Alastair HotblackCancer Institute, University College London, London, United Kingdom.
Mark F LythgoeCentre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
Bruce R BranchiniDepartment of Chemistry, Connecticut College, New London, United States.
Tammy L KalberCentre for Advanced Biomedical Imaging, University College London, London, United Kingdom.
James C AndersonDepartment of Chemistry, University College London, London, United Kingdom.ORCID 0000-0001-8120-4125
Martin A PuleCancer Institute, University College London, London, United Kingdom.
University College London · GBInstitute of Cancer Research · GBConnecticut College · US

Funding

Cancer Research UK 16464
6 · The paper itself

Abstract

Bioluminescence imaging (BLI) is ubiquitous in scientific research for the sensitive tracking of biological processes in small animal models. However, due to the attenuation of visible light by tissue, and the limited set of near-infrared bioluminescent enzymes, BLI is largely restricted to monitoring single processes in vivo. Here we show, that by combining stabilised colour mutants of firefly luciferase (FLuc) with the luciferin (LH

Indexed as

AnimalsCrystallography, X-RayDisease Models, AnimalLuminescent MeasurementsLuminescent ProteinsMaleMiceNeoplasmsNeoplasm TransplantationOptical ImagingProtein ConformationRecombinant Fusion ProteinsLuminescent ProteinsRecombinant Fusion ProteinsbiochemistrybioluminescenceCAR T cellschemical biologydual imaginginfraluciferinluciferase crystal structuremolecular biophysicsmousenear infraredstructural biology

Identifiers

PMID31610848
PMCPMC6828332
OpenAlexW2980933082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.